Facts & Figures

Fighting the battle on opioid use disorder in Western New York


Regional hospital systems, through the Buffalo Matters network are partnering with community-based substance use treatment programs as well as the John R. Oishei Foundation, the Erie County and New York State Departments of Health and local hospitals to increase access to Buprenorphine based opiate use disorder treatment for the citizens of Western New York.


  • To aid our shared patients in initiating and continuing successful opiate use disorder treatment.
  • To reduce morbidity and mortality associated with opiate use disorder in Western New York.
  • To provide a best practice model for Emergency Department Initiated Buprenorphine Programs that others can emulate. To provide the same high level of care to patients suffering from opiate use disorder that we would for any other emergency medical condition.

Blue –  current Clinic Partners
Black – current Hospital Partners
Yellow – future Hospital Partners
BrownNetwork Pharmacies


Hospital Partners will follow these values:

  • We will prescribe buprenorphine for patients when appropriate based on our guidelines.
  • We will not automatically disqualify patients from receiving buprenorphine if they engage in polysubstance abuse (especially benzodiazepines and/or alcohol).
  • We will refer patients to the most appropriate follow up possible based on their unique needs.
  • We will inform patients of the referral program’s expectations.
  • We will continuously evaluate our program and share our lessons learned with others
Buffalo Matters will partner with community-based substance use treatment programs that embody these values:

  • They will accept and work with patients regardless of insurance status.
  • They will accept ED patients who have not been prescribed buprenorphine in the past.
  • They will offer timely appointments to patients referred from the emergency department.
  • They will accept referred patients even if previously discharged from a treatment program.
  • They will not automatically disqualify patients from receiving medication assisted treatment if they engage in polysubstance abuse (especially benzodiazepines and/or alcohol).
  • They will not place undue financial burden on the patient.
  • They will provide care that is culturally appropriate for the target population of patients with substance use disorder.
  • They will provide feedback to UBMD regarding the disposition of referred patients to improve our processes.

Hospital Partners

  • Kaleida Health
  • Catholic Health
  • ECMC
  • Niagara Falls Memorial Medical Center
  • Brooks-TLC Health System
  • Wyoming County Community Hospital

Treatment Center Partners

  • Evergreen Health
  • Endeavor Health
  • Best | Self
  • Beacon Center
  • Horizon Health Services
  • St. Vincent’s Medical Center
  • Spectrum Health & Human Services
  • MCCC
  • OLV
  • TLC Healthcare
  • Northpointe Council
  • CASA-Trinity
  • The Chautauqua Center

Other Partners

  • Mercy Flight of WNY
  • Abbey Mecca & Co.
  • Erie County Department of Health
  • New York State Department of Health
  • Erie County Opiate Epidemic Task Force
  • UB|MD Emergency Medicine
  • John R. Oishei Foundation
  • Praxair
  • New York State DOH AIDS Institute
  • University at Buffalo Research Foundation
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences



Latest News

April 8, 2019

NYS Department of Health Leads Multistate Effort to Call on the Federal Government to Improve Access to Buprenorphine to Treat Opioid Disorder April 8, 2019 Coalition of 22 States and Territories Calls for Changes to Outdated Federal Policy Calls for Increasing the Cap on How Many Patients can be Treated and…
All News

From Twitter

@matters_network @JMPerroneMD @LeoBeletsky @AnnalsofEM @highlandherring @LNelsonMD @PA_ACEP Sounds like a very good setup you have there. That is an uncommon scenario nationwide as buprenorphine MAT is still hard to obtain in many areas.

Buprenorphine for opioid withdrawal-essentially the same pathway as induction. Don’t let patients suffer with zofran and clonidine when buprenorphine will mitigate withdrawal symptoms and give time to consider treatment +recovery @AnnalsofEM @highlandherring @LNelsonMD @PA_ACEP

Excellent overview of the Indivior indictment by ⁦⁦@alisonknopf⁩ for ⁦@Filtermag_org⁩ with important quote by ⁦@LeoBeletsky⁩:

“This is not an indictment of the medication, but of the pharmaceutical industry.”

Load More...


For more information or to become a partner, please contact us.

If seeking help for opioid abuse disorder, please refer to the “HOW TO GET HELP” section at the bottom of this page.

How to Get Help

24-Hour WNY Addiction Helpline



24-Hour National Addiction Helpline

1-800-662-HELP (4357)